focus
Previous article:
Drug repurposing or repositioning? The language matters
Next article: Why Novartis is going to walk from its acquisition of MorphoSys
Next article: Why Novartis is going to walk from its acquisition of MorphoSys
knowledge
focus
-
Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards
2025-09-03 08:49 -
Recent heat wave in the Mediterranean caused by climate change: Study
2025-09-03 08:43 -
Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards
2025-09-03 08:42 -
Johnson & Johnson sued for allegedly overpaying for workers' drugs
2025-09-03 07:51 -
Eisai exec who led development of Alzheimer’s drug to retire
2025-09-03 07:13 -
Problems with a popular proposal to regulate AI in health care
2025-09-03 07:12